AI Revolutionizing Target Identification in Drug Discovery for Better Therapies
Transforming Drug Discovery with AI
The landscape of drug discovery is undergoing a seismic shift, primarily driven by advances in artificial intelligence (AI). Target identification, which is the initial and crucial stage of drug development, has historically been a lengthy process, often taking years or even decades. However, companies like Insilico Medicine are at the forefront of integrating AI into this process, making it faster and more accurate than ever.
Understanding Target Identification
In drug discovery, target identification involves selecting a biological entity, typically a gene or protein, that can be modulated to achieve a therapeutic outcome. This choice is foundational because it dictates the entire research pathway. The challenge lies in identifying targets that are not only effective in treating diseases but are also safe to manipulate. Given that the human genome contains approximately 20,000 protein-coding genes, only about 4,500 are considered
Topics Other）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.